Clinical efficacy and safety (phase II and III studies)
BioVentures Consulting Limited understands the regulation of clinical trials in Europe, the EU Clinical Trial Directive, including its implementation in the UK.
"We have managed pivotal trails through the critical path"
BioVentures Consulting Limited has designed and project managed pivotal phase III clinical trials across a number of therapeutic areas including oncology, neurology, cardiology, gastroenterology, obesity and women’s sexual health. BioVentures Consulting Limited can advise on the selection of clinical endpoints (including biomarkers) and dose level selection for phase II and III trials.
BioVentures Consulting Limited has particular expertise in the project management of pivotal phase III trials. We have managed pivotal trails through the critical path on a day-by-day, activity-by-activity basis and adhered to the project risk log. BioVentures Consulting Limited is familiar with patient recruitment issues, and strategies to keep the project on-track in terms of timelines, cost and resource predictions. BioVentures Consulting Limited is able to supply interim clinical project management services to manage its client’s clinical operations activities.